Role of the Ketogenic Diet Therapy and ACTH as Second Treatments in Drug-Resistant Infantile Epileptic Spasms Syndrome
Nutrients · 2025
DOI: 10.3390/nu17132085 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Anastasia Dressler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, ERN EpiCARE, Medical University Vienna, A-1090 Wien, Austria. Hauptthemen laut MEDLINE: Diet, Ketogenic, Spasms, Infantile, Adrenocorticotropic Hormone, Drug Resistant Epilepsy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The aim of this study was to evaluate the effectiveness of sequential treatments with adrenocorticotropic hormone (ACTH) or ketogenic diet therapy (KDT) in infants with infantile epileptic spasms syndrome (IESS) who did not achieve seizure freedom after initial treatment with either KDT or ACTH.
Methods
We conducted a cohort study following a parallel-cohort randomized controlled trial comparing KDT with ACTH as first-line treatment for IESS. Infants who failed to respond were switched per protocol to the alternative treatment (ACTH or KDT) or, if this was not feasible or unsuccessful, to anti-seizure medications (ASMs). The primary outcome was the frequency of sustained seizure freedom at last follow-up.
Results
Of 101 infants allocated to the initial treatment phase, N = 67 required further treatment. Of these, 31% (21/67) achieved sustained seizure freedom after the second treatment phase, and 15% (7/46) after rescue treatment with ASMs. KDT as the second treatment achieved sustained seizure freedom in 50% (12/24), compared to 19% (3/16) with ACTH and 9% (2/22) with ASMs. The cumulative response rate after the first and second treatments was 64% for the KDT-ACTH sequence and 68% for the ACTH-KDT sequence. The cumulative response after all three treatment phases was 78% (KDT-ACTH-ASM) and 72% (ACTH-KDT-ASM), respectively.
Conclusions
KDT is at least as effective as ACTH as a second treatment and significantly more effective than ASMs in achieving sustained seizure freedom in infants with IESS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, ERN EpiCARE, Medical University Vienna, A-1090 Wien, Austria.
- Postgraduate School of Clinical Nutrition, University of Milan, 20122 Milan, Italy.
- IRCCS Auxologico Italiano, Research Laboratory on Nutrition and Obesity, 20145 Milan, Italy.
- Department of Food, Environmental and Nutrional Sciences (DeFENS), University of Milan, 20122 Milan, Italy.
ORCID-Profile: Anastasia Dressler, Barbara Porsche, Simona Bertoli, Christoph Male
Zitieren
APA
Dressler, A., Bonfanti, L., Trimmel-Schwahofer, P., Porsche, B., Bertoli, S., & Male, C. (2025). Role of the Ketogenic Diet Therapy and ACTH as Second Treatments in Drug-Resistant Infantile Epileptic Spasms Syndrome. Nutrients. https://doi.org/10.3390/nu17132085
Vancouver
Dressler A, Bonfanti L, Trimmel-Schwahofer P, Porsche B, Bertoli S, Male C. Role of the Ketogenic Diet Therapy and ACTH as Second Treatments in Drug-Resistant Infantile Epileptic Spasms Syndrome. Nutrients. 2025. doi:10.3390/nu17132085
BibTeX
@article{Dressler2025,
author = {Dressler, Anastasia and Bonfanti, Letizia and Trimmel-Schwahofer, Petra and Porsche, Barbara and Bertoli, Simona and Male, Christoph},
title = {Role of the Ketogenic Diet Therapy and ACTH as Second Treatments in Drug-Resistant Infantile Epileptic Spasms Syndrome},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17132085}
}
EUVIMED